drugset / Trial / NCT00333944
Study to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether high doses of pralidoxime(PAM) are effective as compare to lower doses of PAM in the management of moderately sever organophosphorus poisoning patients.
Timeline
- Start
- 2000-05
- Primary completion
- —
- Completion
- 2003-06
Outcome
Met primary endpoint
paper required less atropine during the first 24 h than controls (median 6 mg vs 30 mg; difference 24 mg [95% CI 24-26, p<0.0001]). PMID 17174705 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pralidoxime | Small molecule | 1 g | Intravenous |